Clinical Trials Browser

Phase 2 × NETWORK × selinexor × Clear all

NCT02436707 2026-03-27

Novel Combination Therapy in the Treatment of Relapsed and Refractory Aggressive B-Cell Lymphoma

Phase 2 Active not recruiting

Lymphoma